Nidan Laboratories and Healthcare Limited IPO

Nidan Laboratories and Healthcare Limited IPO Review

Dr Nitin Vithalrao Throve founded Nidan as a private company in the Northern District of Mumbai in 1994. The firm was run as a sole proprietorship until it was taken over by the corporation in 2000. He grew the diagnostics business beginning in the year 2000, and the company now has 30 diagnostics cum collection facilities under the brand name “Nidan Healthcare,” which provides radiology, neurology, cardiology, dentistry, and pathology services. It offers a comprehensive spectrum of roughly 740 standard and 3,000 specialised pathology tests, as well as approximately 220 basic and 320 advanced radiology tests, as of March 31, 2021, covering a variety of specialities and disciplines.

Former medical directors such as Dr. Shailesh Barrot, a well-known paediatrician in Mumbai, and Dr. Suresh Sonawane, a top physician, helped the organisation expand. Since 2000, Dr. Ashish Jain, a Senior Radiologist, has served as the CEO of Nidan Healthcare. Its diagnostic services are given by a medical professional team in its operating network consisting of 94 laboratory doctors, radiologists, physicians, and 256 well-trained technical employees as of March 31, 2021. All of its centres have received Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) certification as of June 30, 2021.

Nidan’s test selection includes pathology tests ranging from simple biochemistry and clinical pathology to cytogenetic and greater molar diagnostic testing, as well as radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to sophisticated radiology tests such as CT scans and MRI scans. It also provides a wide range of health and wellness packages to its consumers, depending on their needs.

Subscription Dates

28 October – 2 November 2021

Price Band

INR125 per share

Fresh issue

4,000,000 shares (INR50 crore)

Offer For Sale

Nil

Total IPO size

4,000,000 shares (INR50 crore)

Minimum bid (lot size)

1,000 shares

Face Value 

INR10 per share

Retail Allocation

50%

Listing On

NSE Emerge SME platform

 

FY2019

FY2020

FY2021

Q1 FY2022

Revenue

2,097.2

2,219.2

2,185.3

784.6

Expenses

2,074.9

2,147.7

1,855.1

644.3

Net income

22.4

71.5

230.2

108.7

Earnings Per Share (EPS): INR2.32

Price/Earnings (PE ratio): 53.88

Return on Net Worth (RONW): 0.17%

Net Asset Value (NAV): INR13.46 per share

Listing Performance of Nidan Laboratories and Healthcare Limited IPO

Company Name

Listed On

Issue Price

Listing Day Close

Listing Day Gain

Nidan Laboratories and Healthcare Limited IPO

Nov 12, 2021

125

117.75

-5.8

NSE : NA

ISIN CODE : INE0J6L01013

BSE :  NIDAN

IPO Opening Date: 28 October 2021

IPO Closing Date: 2 November 2021

Finalisation of Basis of Allotment: Coming soon

Initiation of refunds: Coming soon

Transfer of shares to demat accounts: Coming soon

Listing Date: Coming soon

Opening Price on NSE: Coming soon

Closing Price on NSE: Coming soon

Nidan Laboratories and Healthcare Limited

Swapnshilpa, Behind Aarti Apartment

Vartak Road, Virar (West) – 401303

Palagar, Maharashtra

Phone: +91 8975610000

Email: cs@nidanhealthcare.co.in

Website: www.nidanhealthcare.co.in

Bigshare Services Private Limited

1st Floor, Bharat Tin Works Building, Opp. Vasant Oasis

Makwana Road Marol, Andheri (East), Mumbai – 400059

Phone: +91 22 6263 8200

Email: ipo@bigshareonline.com

Website: www.bigshareonline.com

Category

Non-retail

Retail

Total

Shares Offered

21,00,000

19,00,000

40,00,000

Day 1

0.01

1.13

0.54

Day 2

0.02

1.81

0.87

Day 3

0.12

2.74

1.37

Day 4

0.14

3.44

1.71

Nidan Laboratories and Healthcare Limited IPO FAQ's

Nidan Laboratories and Healthcare Limited IPO is a SME IPO of ₹125 per equity share with a face value of ₹10 per equity share.
The issue size is priced at 4,000,000 Eq Shares of ₹10 (aggregating up to ₹50.00 Crore). The initial public offering (IPO) begins on Oct 28, 2021 and ends on Nov 2, 2021. The minimum order quantity is 1000 Shares and Market Lot size is 1000 shares.
The registrar for the IPO is Link Intime India Private Ltd. The shares are proposed for listing on the NSE, SME.

The Nidan Laboratories and Healthcare Limited IPO opening date is Oct 28, 2021 and closing date is Nov 2, 2021.

Nidan Laboratories and Healthcare Limited IPO Market lot size is 1000 Shares and the minimum order quantity is 1000 Shares.

Nidan Laboratories and Healthcare Limited IPO can be submitted online using either UPI or ASBA as a payment method. The ASBA IPO application is available in your bank’s net banking. Brokers who do not provide banking services provide UPI IPO applications. Learn more about online IPO applications from Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank, and SBI Bank.

The Basis of Allotment for Nidan Laboratories and Healthcare Limited IPO will be done on Nov 9, 2021 and the allotted shares will be credited to your demat account by Nov 11, 2021. Check the Nidan Laboratories and Healthcare Limited IPO allotment status.

The Nidan Laboratories and Healthcare Limited IPO listing date is Nov 12, 2021.

Nidan Laboratories and Healthcare Limited IPO Comments